Implantica AG (OSTO:IMP A SDB) EV-to-EBITDA : (As of Jun. 26, 2025)

View and export this data going back to 2020. Start your Free Trial

What is Implantica AG EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Implantica AG's enterprise value is kr0.00 Mil. Implantica AG does not have enough years/quarters to calculate its EBITDA for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate Implantica AG's EV-to-EBITDA at this moment.

The historical rank and industry rank for Implantica AG's EV-to-EBITDA or its related term are showing as below:

OSTO:IMP A SDB's EV-to-EBITDA is not ranked ^*
in the Medical Devices & Instruments industry.
Industry Median: 15.32
* Ranked among companies with meaningful EV-to-EBITDA only.

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2025-06-26), Implantica AG's stock price is kr44.00. Implantica AG does not have enough years/quarters to calculate its Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate Implantica AG's PE Ratio (TTM) at this moment.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).

Implantica AG EV-to-EBITDA Historical Data

The historical data trend for Implantica AG's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Implantica AG EV-to-EBITDA Chart

Implantica AG Annual Data

Trend

EV-to-EBITDA

Implantica AG Semi-Annual Data

EV-to-EBITDA

Competitive Comparison of Implantica AG's EV-to-EBITDA

For the Medical Devices subindustry, Implantica AG's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Implantica AG's EV-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Implantica AG's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Implantica AG's EV-to-EBITDA falls into.

Save Embed

;

Save Embed

;

Implantica AG EV-to-EBITDA Calculation

Implantica AG's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA	=	Enterprise Value (Today)	/	EBITDA (TTM)
	=	0.000	/
	=

Implantica AG (OSTO:IMP A SDB) EV-to-EBITDA Explanation

Implantica AG's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)	=	Share Price (Today)	/	Earnings per Share (Diluted) (TTM)
	=	44.00	/
	=

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).

Please read Which price ratio outperforms the enterprise multiple?

Implantica AG EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Implantica AG's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Implantica AG Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Implantica AG (OSTO:IMP A SDB) » Definitions » EV-to-EBITDA

Comparable Companies

Traded in Other Exchanges

8IM1:Germany

Address

Aeulestrasse 45, Vaduz, LIE, 9490

Website

https://www.implantica.com

Implantica AG is a medtech group providing effective care for serious health conditions and improving patients' quality of life by bringing advanced technology into the body. The therapies Implantica develops are based on implants that are medical devices inserted into the patient's body and are intended to remain in place permanently or semi-permanently, using electrical power provided by a battery. The company has developed a broad, patent-protected, product pipeline based partly on its two platform technologies. Its lead product, RefluxStop, is a CE-marked implant for the prevention of gastroesophageal reflux that will potentially create a paradigm shift in anti-reflux treatment as supported by successful clinical trial results.

Implantica AG Headlines

No Headlines